SCHEMBL26036716

SCHEMBL26036716

CC(O)c1cccc(C(C)(C)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 3/20 0.48
CES2 O00748 1/20 0.46
PNMT P11086 1/20 0.46
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
UGT2B7 P16662 1/20 0.41
ACP3 P15309 1/20 0.39
ACHE P22303 1/20 0.39
DAO P14920 1/20 0.38
BRD4 O60885 1/20 0.37
BRD2 P25440 1/20 0.37
CREBBP Q92793 1/20 0.37
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
ALDH1A1 P00352 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
PDE2A O00408 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29755658 0.89 PTPN5 (0.48) PTPN5CES2PNMTMEN1KMT2A
SCHEMBL1044909 0.86 PNMT (0.61) PTPN5CES2PNMTACP3DAO
SCHEMBL1535283 0.86 PNMT (0.61) PTPN5CES2PNMTACP3DAO
SCHEMBL343403 0.86 PNMT (0.61) PTPN5CES2PNMTACP3DAO
SCHEMBL29404730 0.86 PNMT (0.61) PTPN5CES2PNMTACP3DAO
SCHEMBL475370 0.84 HDAC4 (0.46) PTPN5CES2PNMTMEN1KMT2A
SCHEMBL19766262 0.80 PTPN5 (0.44) PTPN5CES2PNMTMEN1KMT2A
SCHEMBL20812100 0.80 PNMT (0.42) PTPN5CES2PNMTACP3ACHE
SCHEMBL31085000 0.77 SCN10A (0.41) PTPN5CES2PNMTMEN1KMT2A
SCHEMBL9331659 0.76 UGT2B7 (0.56) PTPN5MEN1KMT2AUGT2B7BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 WO disclosed